Honeywell launches authentication tech to forestall counterfeit pharma medicine



on Monday announced

digital authentication technology for the pharmaceutical industry in response to the growing menace of counterfeit products.


An acute shortage of drugs to treat symptoms of COVID-19 has led to increased circulation of counterfeit medicines in recent times, a company statement said.





It added that there are reports of fake antiviral medicines and spurious injectable immunosuppressants in the market.


With rising demand for vaccines, there is concern that fake vaccines could find their way into circulation.


Earlier this year, the World Health Organisation sounded an alarm over criminal exploitation of an unmet global demand for COVID-19 vaccines.


Already, counterfeit vaccines have been detected in countries such as Mexico and Poland.


The solution comprises a digital code that is embedded in the packaging of pharmaceutical products.


The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphoneletting the end user know it is safe to use.


“The software that validates the product’s authenticity through a database is accessible through a app available for download for iOS and Android users and gathers market intelligence,” the statement added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Leave a Comment